Current progress for the use of miRNAs in glioblastoma treatment.
about
MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancerThe role of microRNAs in intrahepatic cholangiocarcinomaMicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.The NFL-TBS.40-63 anti-glioblastoma peptide disrupts microtubule and mitochondrial networks in the T98G glioma cell lineMicroarray Analysis in Glioblastomas.miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.MicroRNA-141 inhibits glioma cells growth and metastasis by targeting TGF-β2.MiR-592 functions as a tumor suppressor in glioma by targeting IGFBP2.The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma.MicroRNA-217 inhibits cell proliferation and invasion by targeting Runx2 in human glioma.MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.MicroRNA-mRNA expression profiles associated with medulloblastoma subgroup 4.Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9.MicroRNA-671-3p promotes proliferation and migration of glioma cells via targeting CKAP4
P2860
Q26865667-6496EDE7-6128-45B7-B8B1-E4C09EE69243Q28067652-A727022F-EA5D-4EFC-9377-3E45F8446C21Q33622651-4F330411-05A4-4AAF-87CB-4BBCDAABD611Q33627880-A77228F6-75D0-4A93-BEBE-A8E7E21DFBC2Q34409620-AB62F942-4EA9-478C-800E-5106E78B51ACQ35181388-EA771B04-A3F4-48B1-9B36-039A4EAEEAF2Q35675093-D3A6425D-9A6D-49E5-9E87-EEDCA744CF3EQ36545707-A797C7BD-7BB8-4E6B-A964-810D2E02F05FQ36782586-65E65C83-6BE4-4224-AB6D-45FA9C98DF92Q37228013-F129C62D-66C9-4BEE-B99C-DB170EBB8CDEQ38696999-F9663804-9C7C-4D4F-B694-58030FB34D9CQ39091713-914CFEA4-609A-4E65-B066-2AD3BCD4F3B0Q41124472-0EB39E02-7048-48CA-8FBB-39FCD7F40B6CQ47109964-D6C101A2-46A5-458E-AE60-F7E227788004Q52678065-A5CAC6AA-C21E-4952-AC9E-3E0A8C0E4D8EQ55138983-E810480A-4576-418A-BE39-91CE417265D2Q57069981-484DC49D-FCDB-4AC4-8378-8C7A09A6FA00
P2860
Current progress for the use of miRNAs in glioblastoma treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current progress for the use of miRNAs in glioblastoma treatment.
@en
type
label
Current progress for the use of miRNAs in glioblastoma treatment.
@en
prefLabel
Current progress for the use of miRNAs in glioblastoma treatment.
@en
P2860
P1476
Current progress for the use of miRNAs in glioblastoma treatment.
@en
P2093
Amanda Tivnan
Kerrie Leanne McDonald
P2860
P2888
P304
P356
10.1007/S12035-013-8464-0
P577
2013-04-28T00:00:00Z
P5875
P6179
1015501297